Heron Therapeutics Inc (HRTX)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO, CA 92121

A P Pharma Inc. develops ethical (prescription) pharmaceuticals utilizing its proprietary polymer-based drug delivery systems. The company's main focus is the development and commercialization of its bioerodible injectable and implantable systems under the trade name Biochronomer.

Data based on most recent fiscal year report
Market Cap1.76 Billion Shares Outstanding64.6 Million Avg Volume1.48 Million
1-Yr BETA vs S&P TR Current Ratio2.21 Quick Ratio2.11
View SEC Filings from HRTX instead.
Q1 2019 All Institutions Hedge Funds 1
To trade HRTX now:
Filers who had this stock in their top 10: 11 7 (0.71%)
13F Filers holding this stock: 197 43 (4.38%)
Aggregate 13F shares on 03/31/2019: 92.227 Million 22.418 Million
Aggregate 13F shares on 12/31/2018: 91.349 Million 24.988 Million
Percent change: 0.96% -10.29%
Funds creating new positions: 37 10
Funds Adding to an existing position: 76 14
Funds closing out their position: 13 2
Funds reducing their position: 51 14
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

 

Heron Therapeutics Inc Chart by YCharts

Yahoo! Finance

finviz

Check out our reporting and analysis

Funds Holding HRTX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

1.4 Thousand total shares from 1 transactions

Open Market Sells (S)

1.1 Thousand total shares from 1 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

CHRISTIAN WAAGE

  • Director
 1,400 2019-05-15 2

ZERBE ROBERT L MD

0 2019-05-01 0

MANHARD KIMBERLY EXECUTIVE VP, DRUG DEVELOPMENT

  • Officer
 0 2019-05-01 5

HOFFMAN ROBERT

  • Director
 0 2019-04-30 2

DAVIS STEPHEN PRESIDENT AND CEO

  • Officer
  • Director
 0 2019-04-29 0

JOHNSON CRAIG A

0 2019-01-29 1

TANG KEVIN C

  • Director
  • 10% Owner
 0 2019-01-23 2

ROSEN ROBERT

  • Director
 0 2019-01-23 2

TANG KEVIN C

TANG CAPITAL PARTNERS LP

TANG CAPITAL MANAGEMENT LLC

  • Director
  • 10% Owner
 4,938,893 2019-01-07 2

QUART BARRY D CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
 0 2018-12-15 3

POYHONEN JOHN

  • Director
 0 2018-12-15 1

GODDARD PAUL

  • Director
 No longer subject to file 2018-11-27 0

DRAZBA BRIAN G. CHIEF FINANCIAL OFFICER

  • Officer
 0 2018-07-12 0

CLENDENINN NEIL JAMES

  • Director
 0 2016-05-26 0

MARSHALL PAUL SVP, TECHNICAL OPERATIONS

  • Officer
 2,200 2016-03-21 0

SPCH, LLC

MIDLER ANDREW R

  • EXITING 10% HOLDEREXITING 10% HOLDER
 No longer subject to file 2014-12-31 0

SAVITR CAPITAL, LLC

  • EXITING 10% HOLDER
 No longer subject to file 2014-12-31 0

GELDER MARK S. MD SVP & CHIEF MEDICAL OFFICER

  • Officer
 0 2014-12-12 0

TURNBULL GREG

  • Director
 167,074 2014-02-27 0

WHELAN JOHN CFO

  • Officer
 254,088 2013-07-18 0

ADAM MICHAEL A CHIEF OPERATING OFFICER

  • Officer
 0 2013-02-08 0

SPCH, LLC

  • 10% Owner
 0 2013-01-01 0

BAKER BIOTECH CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • 10% Owner
 232,011 2012-03-12 0

14159 CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • 10% Owner
 57,704 2012-03-12 0

BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC

BAKER FELIX

BAKER JULIAN

  • 10% Owner
 2,328,863 2012-03-12 0

BAKER BROS. CAPITAL (GP), LLC

BAKER FELIX

BAKER JULIAN

  • 10% Owner
 0 2012-01-27 0

BAKER / TISCH CAPITAL (GP), LLC

BAKER JULIAN

BAKER FELIX

  • Director
  • 10% Owner
 450,461 2011-12-30 0

BARR JOHN VICE PRESIDENT OF R&D

  • Officer
 0 2011-07-08 0

PERCEPTIVE ADVISORS LLC

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD

  • 10% Owner
 26,666,667 2011-07-01 0

ROSENBLATT TOBY

  • Director
 210,234 2010-05-20 0

PRENTKI RONALD J PRESIDENT & CEO

  • Officer
  • Director
 0 2010-02-17 0

TAYLOR ARTHUR T

  • Director
 0 2008-06-18 0

RIEPENHAUSEN PETER

  • Director
 71,900 2008-02-28 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

CHRISTIAN WAAGE - Director

2019-05-15 P 1,400 $18.04 a 1,400 1,400.00 direct

MANHARD KIMBERLY - Officer EXECUTIVE VP, DRUG DEVELOPMENT

2019-05-01 S 1,109 $18.86 d 0 0.00 direct yes

MANHARD KIMBERLY - Officer EXECUTIVE VP, DRUG DEVELOPMENT

2019-04-30 J 1,109 $18.43 a 1,109 0.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments